US · Healthcare · Medical Devices
EPS came in at -0.08 against a street estimate of -0.08 — a beat of 0.0%.
Analysts rate Microbot Medical Inc a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $6.33.
| Fund | Stake |
|---|---|
| Vanguard Capital Management, LLC | 4.33% |
| Mitsubishi UFJ Asset Management Co.,Ltd | 1.89% |
| BlackRock Inc | 1.34% |
| Geode Capital Management, LLC | 1.25% |
| UBS Group AG | 1.20% |
| DnB NOR Asset Management (Asia) | 1.01% |
| Stifel Financial Corp | 0.88% |
| Marshall Wace Asset Management Ltd | 0.81% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Microbot Medical Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.